Immediate Impact
17 standout
Citing Papers
Cancer stem cells: advances in knowledge and implications for cancer therapy
2024 Standout
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Works of Ian Geh being referenced
Well-differentiated gastroenteropancreatic G3 NET: findings from a large single centre cohort
2021
Complete response to neoadjuvant chemoradiotherapy in rectal cancer is associated with RAS/AKT mutations and high tumour mutational burden
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ian Geh | 305 | 311 | 89 | 21 | 452 | |
| Seth A. Rosen | 248 | 226 | 105 | 23 | 427 | |
| Margaret M. Byrne | 134 | 183 | 55 | 20 | 452 | |
| Elizabeth C. Riley | 150 | 146 | 52 | 28 | 433 | |
| Nikhil Pawa | 240 | 283 | 74 | 25 | 444 | |
| Sahael M. Stapleton | 98 | 244 | 89 | 24 | 444 | |
| Nicholas G. Berger | 184 | 190 | 92 | 23 | 418 | |
| Katherine A Buhler | 105 | 199 | 33 | 17 | 444 | |
| Alberto Manno | 255 | 280 | 78 | 30 | 392 | |
| C Armbruster | 175 | 288 | 89 | 29 | 460 | |
| Nathalie Audet | 138 | 196 | 49 | 18 | 387 |
All Works
Loading papers...